アルツハイマー病のX関連脆弱性を発見
1Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Lieber Institute for Brain Development, Baltimore, MD 21205, USA.
Cell
|October 14, 2022
まとめ
女性
科学分野:
- 神経科学
- 遺伝学
- 生物化学
背景:
- 女性にはアルツハイマー病 (AD) や他のタオパシーのリスクが高くなります.
- この増加したリスクを誘発する特定の生物学的メカニズムは,ほとんど不明です.
- 神経繊維の絡み合いは,ADの病理学的特徴です.
研究 の 目的:
- 女性におけるアルツハイマー病とタオパシーの高頻度の原因である分子メカニズムを調査する.
- 女性脳におけるタウのクリアランスの低下に寄与する特定の要因を特定する.
主な方法:
- タウ病理の文脈におけるUSP11デウビキチナーゼ活性に関する分析.
- 神経変性疾患のメカニズムにおけるX関連遺伝子の役割の調査.
- タンパク質のクリアランス経路,特にタウ分解に焦点を当てた研究
主要な成果:
- X結合USP11デウビキチナーゼの異常な高活性が女性で確認された.
- この上昇したUSP11は,タウタンパク質のクリアランスを低下させることが示された.
- 発見はUSP11の調節不全と神経線維の絡み合いの蓄積を関連付けています.
結論:
- 女性におけるUSP11デウビキチナゼ活性の増加は,タウのクリアランスの低下に寄与する.
- このメカニズムは女性におけるアルツハイマー病とタオパシーの高リスクの 潜在的な説明となる.
- USP11は,女性におけるタウ病変の緩和のための潜在的な治療目標を表しています.
関連する概念動画
01:26Alzheimer's Disease: Overview
628
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
628
01:43Sex-linked Disorders
102.7K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
102.7K
01:19X-linked Traits
55.1K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
55.1K
01:22Alzheimer's Disease: Treatment
247
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
247
01:35Pedigree Analysis
84.8K
Overview
84.8K
01:11Genetic Lingo
103.8K
Overview
103.8K